| Frederick William Kahn, MD | |
|
2900 12th Ave N, Suite 300e, Billings, MT 59101-7506 | |
| (406) 238-6800 | |
| (406) 238-6814 |
| Full Name | Frederick William Kahn |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 44 Years |
| Location | 2900 12th Ave N, Billings, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942295134 | NPI | - | NPPES |
| 0078637 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 5284 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent Healthcare | Billings, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scl Health Medical Group - Billings Llc | 9638491574 | 219 |
News Archive
Johannes Reiter, former PhD student in the group of Krishnendu Chatterjee at the Institute of Science and Technology Austria (IST Austria), is co-author of a Nature paper on genetic alterations that drive the progression and relapse of cancer.
Researchers from across multiple disciplines at NYU Langone Medical Center created a new protein molecule derived from the growth factor progranulin may provide the basis for new therapies in inflammatory diseases, such as rheumatoid arthritis, according to a study published in the March 10, 2011 issue of Science.
Although pedestrian injuries have decreased in recent years, they still remain a significant health problem, accounting for 13 percent of traffic fatalities in the U.S. The growing popularity of light trucks, a category that includes sport utility vehicles (SUVs), has presented a new challenge for pedestrians and raises an important question: Do light trucks increase the risk of severe injury and death for pedestrians?
Ampio Pharmaceuticals, Inc. today announced it has finalized negotiations with the directors of DMI BioSciences, Inc. (DMI) to acquire DMI BioSciences, Inc. This acquisition will give Ampio access to all rights, royalties and patents associated with DMI's major assets, drugs for male sexual dysfunction including premature ejaculation (PE) and combination drugs to treat premature ejaculation and erectile dysfunction (ED).
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced two-year clinical results for the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device, a Percutaneous Ventricular Restoration (PVR) therapy for patients with ischemic heart failure.
› Verified 2 days ago
| Entity Name | Scl Health Montana |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083655997 PECOS PAC ID: 3476457714 Enrollment ID: O20031229000380 |
News Archive
Johannes Reiter, former PhD student in the group of Krishnendu Chatterjee at the Institute of Science and Technology Austria (IST Austria), is co-author of a Nature paper on genetic alterations that drive the progression and relapse of cancer.
Researchers from across multiple disciplines at NYU Langone Medical Center created a new protein molecule derived from the growth factor progranulin may provide the basis for new therapies in inflammatory diseases, such as rheumatoid arthritis, according to a study published in the March 10, 2011 issue of Science.
Although pedestrian injuries have decreased in recent years, they still remain a significant health problem, accounting for 13 percent of traffic fatalities in the U.S. The growing popularity of light trucks, a category that includes sport utility vehicles (SUVs), has presented a new challenge for pedestrians and raises an important question: Do light trucks increase the risk of severe injury and death for pedestrians?
Ampio Pharmaceuticals, Inc. today announced it has finalized negotiations with the directors of DMI BioSciences, Inc. (DMI) to acquire DMI BioSciences, Inc. This acquisition will give Ampio access to all rights, royalties and patents associated with DMI's major assets, drugs for male sexual dysfunction including premature ejaculation (PE) and combination drugs to treat premature ejaculation and erectile dysfunction (ED).
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced two-year clinical results for the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device, a Percutaneous Ventricular Restoration (PVR) therapy for patients with ischemic heart failure.
› Verified 2 days ago
| Entity Name | Scl Health Medical Group - Billings Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508289703 PECOS PAC ID: 9638491574 Enrollment ID: O20141204001495 |
News Archive
Johannes Reiter, former PhD student in the group of Krishnendu Chatterjee at the Institute of Science and Technology Austria (IST Austria), is co-author of a Nature paper on genetic alterations that drive the progression and relapse of cancer.
Researchers from across multiple disciplines at NYU Langone Medical Center created a new protein molecule derived from the growth factor progranulin may provide the basis for new therapies in inflammatory diseases, such as rheumatoid arthritis, according to a study published in the March 10, 2011 issue of Science.
Although pedestrian injuries have decreased in recent years, they still remain a significant health problem, accounting for 13 percent of traffic fatalities in the U.S. The growing popularity of light trucks, a category that includes sport utility vehicles (SUVs), has presented a new challenge for pedestrians and raises an important question: Do light trucks increase the risk of severe injury and death for pedestrians?
Ampio Pharmaceuticals, Inc. today announced it has finalized negotiations with the directors of DMI BioSciences, Inc. (DMI) to acquire DMI BioSciences, Inc. This acquisition will give Ampio access to all rights, royalties and patents associated with DMI's major assets, drugs for male sexual dysfunction including premature ejaculation (PE) and combination drugs to treat premature ejaculation and erectile dysfunction (ED).
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced two-year clinical results for the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device, a Percutaneous Ventricular Restoration (PVR) therapy for patients with ischemic heart failure.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Frederick William Kahn, MD 2900 12th Ave N, Suite 300e, Billings, MT 59101-7506 Ph: (406) 238-6800 | Frederick William Kahn, MD 2900 12th Ave N, Suite 300e, Billings, MT 59101-7506 Ph: (406) 238-6800 |
News Archive
Johannes Reiter, former PhD student in the group of Krishnendu Chatterjee at the Institute of Science and Technology Austria (IST Austria), is co-author of a Nature paper on genetic alterations that drive the progression and relapse of cancer.
Researchers from across multiple disciplines at NYU Langone Medical Center created a new protein molecule derived from the growth factor progranulin may provide the basis for new therapies in inflammatory diseases, such as rheumatoid arthritis, according to a study published in the March 10, 2011 issue of Science.
Although pedestrian injuries have decreased in recent years, they still remain a significant health problem, accounting for 13 percent of traffic fatalities in the U.S. The growing popularity of light trucks, a category that includes sport utility vehicles (SUVs), has presented a new challenge for pedestrians and raises an important question: Do light trucks increase the risk of severe injury and death for pedestrians?
Ampio Pharmaceuticals, Inc. today announced it has finalized negotiations with the directors of DMI BioSciences, Inc. (DMI) to acquire DMI BioSciences, Inc. This acquisition will give Ampio access to all rights, royalties and patents associated with DMI's major assets, drugs for male sexual dysfunction including premature ejaculation (PE) and combination drugs to treat premature ejaculation and erectile dysfunction (ED).
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced two-year clinical results for the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device, a Percutaneous Ventricular Restoration (PVR) therapy for patients with ischemic heart failure.
› Verified 2 days ago
Charles Wittnam, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2675 Central Ave, Billings, MT 59102 Phone: 406-238-2500 | |
Phillip Embury Griffin, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2938 Rockrim Ln, Billings, MT 59102 Phone: 406-259-7582 | |
Megan B Littlefield, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 123 S 27th St, Billings, MT 59101 Phone: 406-247-3350 Fax: 406-247-3389 | |
Charles Mcclave, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2900 12th Ave N, Suite 160w, Billings, MT 59101 Phone: 406-237-8500 Fax: 406-237-8501 | |
Karen C. Klee, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Brock P. Whittenberger, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Benjamin Girton Plank, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 |